Last reviewed · How we verify

NCT05373225

Shockwave Phonophoresis on Calcaneal Spur Patients

Status unknown NA Last updated 19 July 2022
What this trial tests

NA trial testing Acetic acid shockwave phonophoresis therapy in Calcaneal Spur in 60 participants. Status unknown.

Timeline
15 August 2022
Primary endpoint
15 November 2022
15 December 2022

Quick facts

Lead sponsorBeni-Suef University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment60
Start date15 August 2022
Primary completion15 November 2022
Estimated completion15 December 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Beni-Suef University

Who can join

Adults 35 to 65, any sex, with Calcaneal Spur. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Low energy shockwave has a significant effect on the permeability of tissue. Consequently, it might be used to deliver a substance such as Acetic acid. Accordingly, Shockwave might help to improve the outcomes with calcaneal spur patients. Therefore, the present study might help in the treatment of calcaneal spur patients and also might improve the quality of life in a fast and efficient way.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Calcaneal Spur

Currently open trials in the same condition.

Other Beni-Suef University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05373225.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing